WallStreetZenWallStreetZen

NASDAQ: GBIO
Generation Bio Co Stock

$3.53-0.13 (-3.55%)
Updated May 20, 2024
GBIO Price
$3.53
Fair Value Price
-$0.24
Market Cap
$234.85M
52 Week Low
$0.86
52 Week High
$6.98
P/E
-1.38x
P/B
1.78x
P/S
27.14x
PEG
N/A
Dividend Yield
N/A
Revenue
$9.96M
Earnings
-$169.06M
Gross Margin
100%
Operating Margin
-1,696.87%
Profit Margin
-1,696.9%
Debt to Equity
1.17
Operating Cash Flow
-$57M
Beta
1.79
Next Earnings
Jun 6, 2024
Ex-Dividend
N/A
Next Dividend
N/A

GBIO Overview

Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how GBIO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

GBIO ($3.53) is overvalued by 1,548.25% relative to our estimate of its Fair Value price of -$0.24 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
GBIO ($3.53) is not significantly undervalued (1,548.25%) relative to our estimate of its Fair Value price of -$0.24 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
GBIO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more GBIO due diligence checks available for Premium users.

Be the first to know about important GBIO news, forecast changes, insider trades & much more!

GBIO News

Valuation

GBIO fair value

Fair Value of GBIO stock based on Discounted Cash Flow (DCF)
Price
$3.53
Fair Value
-$0.24
Undervalued by
1,548.25%
GBIO ($3.53) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
GBIO ($3.53) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
GBIO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

GBIO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-1.38x
Industry
8.16x
Market
31.12x

GBIO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.78x
Industry
6.06x
GBIO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

GBIO's financial health

Profit margin

Revenue
$4.1M
Net Income
-$74.5M
Profit Margin
-1,836.4%
GBIO's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
GBIO's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$285.9M
Liabilities
$153.9M
Debt to equity
1.17
GBIO's short-term assets ($226.85M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
GBIO's short-term assets ($226.85M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
GBIO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$31.7M
Investing
-$553.0k
Financing
-$125.0k
GBIO's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

GBIO vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
GBIO$234.85M-3.55%-1.38x1.78x
QURE$235.46M-3.19%-0.78x1.60x
BOLD$236.34M+9.82%N/A-1.67x
GTHX$237.88M+0.44%-7.71x8.58x
ELYM$238.55M-0.61%-15.47x2.24x

Generation Bio Co Stock FAQ

What is Generation Bio Co's quote symbol?

(NASDAQ: GBIO) Generation Bio Co trades on the NASDAQ under the ticker symbol GBIO. Generation Bio Co stock quotes can also be displayed as NASDAQ: GBIO.

If you're new to stock investing, here's how to buy Generation Bio Co stock.

What is the 52 week high and low for Generation Bio Co (NASDAQ: GBIO)?

(NASDAQ: GBIO) Generation Bio Co's 52-week high was $6.98, and its 52-week low was $0.86. It is currently -49.43% from its 52-week high and 310.47% from its 52-week low.

How much is Generation Bio Co stock worth today?

(NASDAQ: GBIO) Generation Bio Co currently has 66,528,840 outstanding shares. With Generation Bio Co stock trading at $3.53 per share, the total value of Generation Bio Co stock (market capitalization) is $234.85M.

Generation Bio Co stock was originally listed at a price of $24.69 in Jun 12, 2020. If you had invested in Generation Bio Co stock at $24.69, your return over the last 3 years would have been -85.7%, for an annualized return of -47.71% (not including any dividends or dividend reinvestments).

How much is Generation Bio Co's stock price per share?

(NASDAQ: GBIO) Generation Bio Co stock price per share is $3.53 today (as of May 20, 2024).

What is Generation Bio Co's Market Cap?

(NASDAQ: GBIO) Generation Bio Co's market cap is $234.85M, as of May 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Generation Bio Co's market cap is calculated by multiplying GBIO's current stock price of $3.53 by GBIO's total outstanding shares of 66,528,840.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.